| # | Drug | Count |
|---|---|---|
| 0 | LATANOPROST | 22 |
| 1 | ACYCLOVIR | 9 |
| 2 | CYCLOSPORINE | 8 |
| 3 | GABAPENTIN | 7 |
| 4 | PREDNISONE | 7 |
| 5 | ETANERCEPT | 6 |
| 6 | VALACYCLOVIR HYDROCHLORIDE | 6 |
| 7 | IBUPROFEN | 5 |
| 8 | INFLIXIMAB | 5 |
| 9 | METHOTREXATE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MINERAL OIL, WHITE PETROLATUM | 1 | 0.0035 |
| 1 | SODIUM HYALURONATE | 1 | 0.0012 |
| 2 | DEFEROXAMINE MESYLATE | 2 | 0.0009 |
| 3 | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | 1 | 0.0009 |
| 4 | NARATRIPTAN | 1 | 0.0007 |
| 5 | VERTEPORFIN FOR INJECTION | 1 | 0.0007 |
| 6 | GATIFLOXACIN | 1 | 0.0006 |
| 7 | LATANOPROST | 22 | 0.0004 |
| 8 | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | 3 | 0.0004 |
| 9 | OFLOXACIN OTIC SOLUTION | 3 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 1 | Quinolone Antimicrobial [EPC] | 3 | 0.0003 |
| 2 | Prostaglandin Analog [EPC] | 24 | 0.0003 |
| 3 | Photoenhancer [EPC] | 1 | 0.0003 |
| 4 | Potassium-sparing Diuretic [EPC] | 3 | 0.0002 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 6 | Carbonic Anhydrase Inhibitor [EPC] | 2 | 0.0001 |
| 7 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 9 | 0.0001 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 9 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 9 | 0.0001 |